These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37278237)

  • 21. [Prevention and treatment of antipsychotic induced weight gain].
    Veerman SRT; Cohen D
    Tijdschr Psychiatr; 2023; 65(4):259-265. PubMed ID: 37323046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptin -2548g/a gene polymorphism in association with antipsychotic-induced weight gain: a meta-analysis study.
    Shen J; Ge W; Zhang J; Zhu HJ; Fang Y
    Psychiatr Danub; 2014 Jun; 26(2):145-51. PubMed ID: 24909251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis.
    Hegde NC; Mishra A; Maiti R; Mishra BR; Mohapatra D; Srinivasan A
    Gen Hosp Psychiatry; 2024; 90():12-21. PubMed ID: 38878592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.
    Alvarez-Jiménez M; González-Blanch C; Vázquez-Barquero JL; Pérez-Iglesias R; Martínez-García O; Pérez-Pardal T; Ramírez-Bonilla ML; Crespo-Facorro B
    J Clin Psychiatry; 2006 Aug; 67(8):1253-60. PubMed ID: 16965204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis.
    Lee K; Abraham S; Cleaver R
    Gen Hosp Psychiatry; 2022; 78():58-67. PubMed ID: 35863294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Decara MS; Fagerlund B; Jepsen JRM; Eriksson F; Fink-Jensen A; Pagsberg AK
    J Am Acad Child Adolesc Psychiatry; 2019 Nov; 58(11):1062-1078. PubMed ID: 30858012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight gain and antipsychotics: a drug safety review.
    Musil R; Obermeier M; Russ P; Hamerle M
    Expert Opin Drug Saf; 2015 Jan; 14(1):73-96. PubMed ID: 25400109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.
    Brandl EJ; Tiwari AK; Lett TA; Shaikh SA; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Hum Psychopharmacol; 2013 Mar; 28(2):183-7. PubMed ID: 23364847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
    Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W
    Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations.
    Stogios N; Humber B; Agarwal SM; Hahn M
    Curr Psychiatry Rep; 2023 Nov; 25(11):707-721. PubMed ID: 37755655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Interventions of Atypical Antipsychotics Induced Weight Gain in the Pediatric Population: A Systemic Review of Current Evidence.
    Al Jumaili W; Muzwagi A; Shah K; Trivedi C; Durga P; Mansuri Z; Jain S; Al Jumaili Y
    Child Psychiatry Hum Dev; 2024 Apr; 55(2):479-487. PubMed ID: 36066654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal.
    Alvarez-Jiménez M; González-Blanch C; Crespo-Facorro B; Hetrick S; Rodríguez-Sánchez JM; Pérez-Iglesias R; Vázquez-Barquero JL
    CNS Drugs; 2008; 22(7):547-62. PubMed ID: 18547125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain.
    Zapata RC; Chaudry BS; Valencia ML; Zhang D; Ochsner SA; McKenna NJ; Osborn O
    Transl Psychiatry; 2021 Jul; 11(1):405. PubMed ID: 34294678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.
    Lu Z; Zhang Y; Sun Y; Liao Y; Kang Z; Feng X; Yan H; Li J; Wang L; Lu T; Zhang D; Huang Y; Yue W
    Psychiatry Res; 2023 Jun; 324():115226. PubMed ID: 37116323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis.
    Bak M; Drukker M; Cortenraad S; Vandenberk E; Guloksuz S
    PLoS One; 2021; 16(2):e0244944. PubMed ID: 33596211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.
    Bushe CJ; Bradley AJ; Doshi S; Karagianis J
    Int J Clin Pract; 2009 Dec; 63(12):1743-61. PubMed ID: 19840151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
    Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.